Scientists used humanized mice to demonstrate the differential immunogenicity of cells derived from autologous induced pluripotent stem cells (iPSCs)
The discovery of induced pluripotent stem cells (iPSCs) has been considered as one of the groundbreaking findings in the history of life science research. This innovation has changed the direction of stem cell research around the world and may represent an ideal cell source for future regenerative therapies. But the fact that iPSCs are derived from an individual’s own body does not eliminate the possibility of immune rejection completely. A research group at UC San Diego previously reported that abnormal gene expression may elicit the immune system to reject certain cells derived from iPSCs.